CMS Offers Informative Take on Physician Prep for Sunshine

05.30.13 | By

CMS wrote an informative Perspective article in the New England Journal of Medicine (NEJM) that highlights the important role of the physician community in the implementation of the Physician Payment Sunshine Act.  With over half of physicians in a recent survey admitting they didn’t k

Ending the Tobacco Epidemic for World No Tobacco Day

05.30.13 | By

As more U.S. cities become smoke free, we’re seeing first hand what the Centers for Disease Control and Prevention is saying – U.S. tobacco use has declined significantly. As a result, I was surprised to learn that worldwide tobacco consumption is actually growing.

Alliance for a Stronger FDA Explains Why Sufficient Funding for FDA is Critical

05.28.13 | By

For more than 50 years, biopharmaceutical companies have partnered with the Food and Drug Administration (FDA) to help ensure the safety and efficacy of medicines. Due to the vital nature of the FDA’s public health oversight, PhRMA supports an empowered agency that is adequately resourced through Congressional appropriations which are supplemented by user fees.

Week in Review: Exercising the Mind & Body for Innovation

05.24.13 | By

If you’re like me, physical education class was a welcome break from history and math. Unfortunately, it is being cut from school programs.

Happy 100th Birthday American Cancer Society

05.24.13 | By

When President Nixon signed the National Cancer Act of 1971, there were three million cancer survivors. Today, there are more than 13 million. By 2022, this number will increase to 18 million.

Bob Hugin’s Call to Action: Protect Medical Innovation

05.23.13 | By

Bob Hugin, Chairman and CEO, Celgene and Chairman of the PhRMA Board, recently sat down with Life Science Leader magazine to talk about the value of medical innovation.  If you haven’t read it already, I urge you to do so because Bob offers some very insightful thoughts on why we as a society should celebrate biopharmaceutical in

Report Highlights Importance of Intellectual Property Protections

05.23.13 | By

With TPP, Indian and other IP infringement and innovation issues shaping international headlines in recent weeks, IP is increasingly being recognized as a central driver of growth, development and access to medicines. A report released today by the Commission on the Theft of American Intellectual Property reinforces IP's critical importance: hundreds of billions of dollars and thousands of U.S.

STEM Education and Future Innovators in America

05.22.13 | By

Did you know that fewer than 40 percent of students who enter college intending to major in a STEM (science, technology, engineering and math) field actually graduate with a STEM degree?

This is very troubling.

Rick Smith Testified Before Congress Today About Why Part D Works

05.22.13 | By

PhRMA’s Rick Smith, Executive Vice President of Policy and Research, testified today in a hearing called, “10 Years Later: A Look at the Medicare Prescription Drug Program,” hosted by the Senate’s Special Committee on Aging.

Protecting IP: Balancing Current and Future Interests

05.22.13 | By

With the 17th round of Trans-Pacific Partnership negotiations taking place in Lima, Peru, the importance of strong U.S. trade and innovation policy is once again front and center. When it comes to protecting intellectual property, it’s critical that negotiators keep in mind the far-reaching implications of pro-IP measures on our economy, health and well being, and society overall.

Pages

Subscribe to RSS - Opinion